Meeting
2021 ASCO Annual Meeting
Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.
Authors
Anna Claire Olsson-Brown
Clatterbridge Cancer Centre, Liverpool, United Kingdom
Anna Claire Olsson-Brown , Mark Baxter , Caroline Dobeson , Laura Feeney , Rebecca Lee , Alec Maynard , Shagufta Mirza , Shefali Parikh , Lisa Jane Rodgers , Abdulazeez Salawu , Rohan Shotton , Nadina Tinsley , Jonathan Heseltine , Jenny Cotton , Daniel Hughes , Steven Zhao , James Parry , Christopher Jones , Michael Rowe , Ann Tivey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Geriatric Models of Care
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 12026)
DOI
10.1200/JCO.2021.39.15_suppl.12026
Abstract #
12026
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Immune-related adverse events and immunotherapy efficacy in patients with cancer: A retrospective study.
First Author: Lyndsey L Prather
Poster
2018 ASCO Annual Meeting
A multidisciplinary toxicity team for cancer immunotherapy-related adverse events.
First Author: Jarushka Naidoo
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world practice patterns, treatment-related toxicity, and survival outcomes in older patients with metastatic renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).
First Author: Lauren Caitlin Curry
Poster
2024 ASCO Genitourinary Cancers Symposium
UNICAB: Cabozantinib in locally advanced or metastatic non‐clear cell renal cell carcinoma post immunotherapy or in those unsuitable for immunotherapy (ANZUP 1802).
First Author: David William Pook